High folate intake during pregnancy may have undiscovered later-life effect in progeny

NewsGuard 100/100 Score

During pregnancy, women are normally advised to take high amounts of multivitamin supplements. In particular, folate is recommended to reduce the risk of neural tube defects in newborns. The problem is that, although vitamins are critical in fetal development, high vitamin doses during pregnancy may cause undesired effects on the offspring later in life (in rats, an obesogenic phenotype is typically observed). A study in the July issue of the journal Epigenetics suggests that feeding the pups a similar high-folate diet can prevent the obesogenic phenotype of mature offspring from rats fed a high-folate diet during pregnancy. The authors explain that the increase in folate content in the pup diet has epigenetic effects (molecular changes in genes without any changes in the DNA sequence) on the hypothalamic mechanisms that regulate food intake. The study, performed in rats and authored by researchers at the Faculty of Medicine from the University of Toronto, has relevance in humans as the effect of increasing amounts of vitamins, especially folate, consumed during pregnancy may have undiscovered later-life effect in the progeny.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prenatal opioid exposure not associated with risk of neuropsychiatric disorders in children